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In post-natal life the inflammatory response is an inevitable consequence of tissue injury. Experimental studies
established the dogma that inflammation is essential to the establishment of cutaneous homeostasis following
injury, and in recent years information about specific subsets of inflammatory cell lineages and the cytokine
network orchestrating inflammation associated with tissue repair has increased. Recently, this dogma has been
challenged, and reports have raised questions on the validity of the essential prerequisite of inflammation for
efficient tissue repair. Indeed, in experimental models of repair, inflammation has been shown to delay healing
and to result in increased scarring. Furthermore, chronic inflammation, a hallmark of the non-healing wound,
predisposes tissue to cancer development. Thus, a more detailed understanding in mechanisms controlling the
inflammatory response during repair and how inflammation directs the outcome of the healing process will
serve as a significant milestone in the therapy of pathological tissue repair. In this paper, we review cellular and
molecular mechanisms controlling inflammation in cutaneous tissue repair and provide a rationale for targeting
the inflammatory phase in order to modulate the outcome of the healing response.
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Introduction
Wound healing is a highly dynamic
process and involves complex interac-
tions of extracellular matrix molecules,
soluble mediators, various resident
cells, and infiltrating leukocyte sub-
types. The immediate goal in repair is
to achieve tissue integrity and home-
ostasis (Martin 1997; Singer and Clark,
1999). To achieve this goal, the healing
process involves three phases that
overlap in time and space: inflamma-
tion, tissue formation, and tissue remo-
deling. During the inflammatory phase,
platelet aggregation is followed by
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Editor’s Note
Wound healing has been recognized as important to health
since the time of Hammurabi. A Sumerian clay tablet (c
2150 BC) described early wound care that included
washing the wound in beer and hot water, using poultices
from substances such as wine dregs and lizard dung and
bandaging the wound. Hippocrates (c 400 BC) detailed the
importance of draining pus from the wound, and Galen (c
130–200 AD) described the principle of first and second
intention healing (Broughton G et al. (2006) A Brief history
of wound care. Plast Reconstr Surg 117:6s). Wound healing
advanced slowly over the centuries, with major advances
in the 19th century in the importance of controlling
infection, hemostasis and necrotic tissue. The discovery
of cytokines and growth factors in the 1950s opened a new
age in wound healing research and led to many important
breakthroughs concerning the basic biology of healing
wounds in the skin. In this issue of the JID, a new
Perspective series focused on wound healing begins. These
articles detail the role of inflammation in wound healing
and fibrosis, the key involvement of fibroblasts, myofibro-
blasts, and keratinocytes in the healing wound, and the
great opportunities that tissue engineering provides to
improve wound healing. Hippocrates recognized that
‘‘Healing is a matter of time, but it is sometimes also a
matter of opportunity.’’ These Perspectives show the great
new opportunities that we now have for understanding and
improving the process of healing wounds of the skin.
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infiltration of leukocytes into the
wound site. In tissue formation, epithe-
lialization and newly formed granula-
tion tissue, consisting of endothelial
cells, macrophages and fibroblasts,
begin to cover and fill the wound area
to restore tissue integrity. Synthesis,
remodeling, and deposition of structur-
al extracellular matrix molecules, are
indispensable for initiating repair and
progression into the healing state.
Cellular responses to injury involve
direct cell–cell and cell–matrix interac-
tions, as well as the indirect crosstalk
between different cell populations by
soluble mediators. Indeed, complex
interactions between the epidermal
and dermal compartment are essential.
During the past decade numerous
factors have been identified that are
engaged in a complex reciprocal dia-
logue between epidermal and dermal
cells to facilitate wound repair (Werner
and Grose, 2003). The sensitive bal-
ance between stimulating and inhibi-
tory mediators during diverse stages of
repair is crucial to achieving tissue
homeostasis following injury.
The inflammatory response is re-
garded as the first of a number of
overlapping processes that constitute
wound healing. In skin repair, the
infiltrating leukocytes are the principal
cellular components of the inflamma-
tory response. They are not only
effector cells combating invading
pathogens but are also involved in
tissue degradation and tissue formation.
As such, an excessive or reduced influx
or activation of infiltrating leukocytes
into the damaged tissue may have
profound effects on downstream cell
migration, proliferation, differentiation,
and ultimately the quality of the heal-
ing response. Continuing progress in
understanding the essential and com-
plex role of the inflammatory response
in wound repair will provide strategies
to modulate diseases with pathologic
tissue remodeling, such as healing
disorders, various chronic inflamma-
tory disease states, and cancer.
Inflammation in physiological wound
repair: cell lineages, functions, and med-
iators
Tissue injury causes the immediate
onset of acute inflammation. It has long
been considered that the inflammatory
response is instrumental to supplying
growth factor and cytokine signals that
orchestrate the cell and tissue move-
ments necessary for repair (Simpson
and Ross, 1972; Leibovich and Ross,
1975). In various experimental animal
models and human skin wounds, it has
been demonstrated that the inflamma-
tory response during normal healing is
characterized by spatially and tempo-
rally changing patterns of various leu-
kocyte subsets (Martin 1997; Singer
and Clark, 1999). The well-defined
chronology of these events is essential
for optimal repair.
PMNs. Immediately after injury extra-
vasated blood constituents form a
hemostatic plug. Platelets and poly-
morphonuclear leukocytes (neutro-
phils, PMN) entrapped and aggregated
in the blood clot release a wide variety
of factors that amplify the aggregation
response, initiate a coagulation cas-
cade, and/or act as chemoattractants
for cells involved in the inflammatory
phase (Szpaderska et al., 2003). Within
a few hours post-injury the bulk of
neutrophils in the wound transmigrate
across the endothelial cell wall of
blood capillaries, which have been
activated by proinflammatory cytokines
IL-1b, tumor necrosis factor-a (TNF-a),
and IFN-g at the wound site, leading to
expression of various classes of adhe-
sion molecules essential for leukocyte
adhesion and diapedesis. Adhesion
molecules which are crucial for neu-
trophil diapedesis include endothelial
P- and E-selectins as well as the ICAM-
1, -2. These adhesins interact with
integrins present at the cells surface of
neutrophils including CD11a/CD18
(LFA-1), CD11b/CD18 (MAC-1),
CD11c/CD18 (gp150, 95), and
CD11d/CD18 (Kulidjian et al., 1999).
Chemokines and their receptors are
most likely crucial mediators for neu-
trophil recruitment during repair (Gil-
litzer and Goebeler 2001; Esche et al.,
2005). These include IL-8, growth-
related oncogene-a, and monocyte
chemoattractant protein-1 (MCP-1) (En-
gelhardt et al., 1998). In addition,
bacterial products, such as lipopoly-
saccharides and formyl-methionyl pep-
tides, which accumulate in the
bacterially infected wound, can accel-
erate the directed neutrophil locomotion.
Recruited neutrophils begin the deb-
ridement of devitalized tissue and
phagocytosis of infectious agents. To
perform this task, neutrophils release a
large variety of highly active antimi-
crobial substances (reactive oxygen
species (ROS), cationic peptides, eico-
sanoids) and proteases (elastase, cathe-
psin G, proteinase 3, urokinase-type
plasminogen activator) (Weiss 1989)
(Table 1). Microarray technology has
recently revealed that migration of
PMNs to skin lesions induces a large
transcriptional activation program,
which may regulate cellular fate and
function and promote wound healing
(Theilgaard-Mo¨nch et al., 2004). De-
spite detailed knowledge on the synth-
esis of mediators released by PMNs and
mechanisms involved in their recruit-
ment and their role in host defense,
these cells can be beneficial or detri-
mental to healing. Experiments in the
1970s showed that depletion of neu-
trophils by antiserum from guinea pigs
did not significantly perturb tissue
repair of incisional wounds under
sterile conditions (Simpson and Ross,
1972). A recent study by Dovi et al.
(2003), using a similar approach of
neutrophil depletion, partially con-
firmed these early studies. Although
dermal repair parameters were not
affected by neutropenia, reepitheliali-
zation was significantly accelerated
(Dovi et al., 2003). However, in this
study it remains unclear whether the
lack of PMNs has a direct, beneficial
effect on reepithelialization or whether
the relative increase in other subsets of
inflammatory cells, such as the macro-
phages, might be responsible for accel-
erated epithelialization. Recent in vitro
studies demonstrated that neutrophils
isolated from sites of repair can mod-
ulate the phenotype and cytokine
profile expression of macrophages,
thereby regulating the innate immune
response during healing (Daley et al.,
2005). In addition, a recent report
shows that closure of excisional
wounds in CD18-depleted mice was
significantly delayed, most likely due to
impaired myofibroblast differentiation
and reduced wound contraction (Peters
et al., 2005). The authors speculated
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that in CD18-deficient wounds, which
are devoid of neutrophils, the lack of
apoptotic neutrophils at the wound site
deprives macrophages of their main
stimulus to secrete transforming growth
factor-b1 (TGF-b1), a key mediator
involved in myofibroblast differentia-
tion. Furthermore, impaired wound
healing is a cardinal feature of human
diseases that are characterized by a
deficiency in PMN function, such as
the leukocyte-adhesion deficiency syn-
drome 1 (Kuijpers et al., 1997) or
disease states of PMN actin polymer-
ization (Roos et al., 1993).
Monocytes/macrophages. Unless sti-
muli for neutrophil recruitment persist
at the wound site, the neutrophil
infiltration ceases after few days, and
expended neutrophils are themselves
phagocytosed by macrophages, which
are present at the wound side within 2
days after injury. Beside resident
macrophages, the major portion of
macrophages at the wound site is
recruited from the blood. Whereas the
extravasation of blood PMN is primar-
ily regulated by the CD11/CD18 com-
plex and ICAMs, emigration of blood
monocytes into the wound is in addi-
tion regulated by the interaction of the
very late antigen-4(a4b1 integrin) and
endothelial vascular cell adhesion mo-
lecule-1 (Issekutz et al., 1995; Cotran
and Mayadas-Norton, 1998). Macro-
phage infiltration into the wound site is
highly regulated by gradients of differ-
ent chemotactic factors, including
growth factors, proinflammatory cyto-
kines, and chemokines macrophage
inflammatory protein 1a, MCP-1,
RANTES) (DiPietro et al., 1998; Frank
et al., 2000; Wetzler et al., 2000;
Werner and Grose 2003). Major
sources of these chemoattractants at
the wound site include platelets
trapped in the fibrin clot at the wound
surface, hyperproliferative keratino-
cytes at the wound edge, fibroblasts,
and leukocytes subsets themselves. As
monocytes extravasate from the blood
vessel they become activated and
differentiate into mature tissue macro-
phages. This transformation implies a
major change in the activation pheno-
type of the macrophages resulting in
significant alterations in gene expres-
sion. There is evidence that the activa-
tion process is directed by mediators
present in the microenvironment, and
this pathway would be crucial for the
proper adaptation of macrophage func-
tion to the specific metabolic require-
ments of the wound site (Gordon,
2003; Pinhal-Enfield et al., 2003; Ra-
manathan et al., 2003). Numerous cell
surface receptors have been described
through which macrophages sense and
respond to their microenvironment,
including Toll-like receptors, comple-
ment receptors, and Fc receptors (Gor-
don 2003; Karin et al., 2006). It
remains a challenge to characterize
and better understand the mutual inter-
play and mechanisms that regulate the
activation state of inflammatory cells in
specific wound environmental condi-
tions. Beside their immunological func-
tions as antigen-presenting cells and
phagocytes during wound repair,
macrophages are thought to play an
integral role in a successful outcome of
the healing response through the synth-
esis of numerous potent growth factors,
such as TGF-b, TGF-a, basic fibroblast
growth factor, platelet-derived growth
factor, and vascular endothelial growth
factor, which promote cell proliferation
and the synthesis of extracellular matrix
molecules by resident skin cells (DiPie-
tro and Polverini, 1993). A crucial role
for macrophages in repair was estab-
lished over 30 years ago. Macrophage
depletion using antisera resulted in a
significant delay of healing (Leibovich
and Ross, 1975). More recent studies
have supported and extended these
observations. Double P- and E-selec-
tin-deficient mice (Subramaniam et al.,
1997), mice deficient in b-1,4-galacto-
syltransferase, which glycosylates the
P- and E-selectins (Mori et al., 2004),
and ICAM-1-deficient mice (Nagaoka
Table 1. Inflammatory cells, their functions and mediators released in
tissue repair
Cell type Functions Mediators
PMN Phagocytosis of infectious agents ROS, cationic peptides, eicosanoids,
proteases (elastase, cathepsinG, PR-3, and
uPA)
Mf activation through phagocytosis
Amplify inflammatory response TNF-a, IL-1b, IL-6
Stimulate repair response VEGF, IL-8
MF Phagocytosis of PMN and fragments of tissue
degradation
Amplify inflammatory response TNF-a, IL-1b, and IL-6
Anti-inflammatory function IL-10, TGF-b1
Stimulate repair response: angiogenesis,
fibroplasia
PDGF, VEGF, bFGF, TGF-a, and TGF-b
Fibrolysis t-PA, uPA, u-PAR, and PAI-1/-2
MC Control vascular permeability Histamine
Control influx of PMN Chymase, tryptase
Regulate tissue remodeling
T cell;
Th1/Th2
Regulate tissue remodeling CD40 ligand; IL-2, TNF-a/ IL-4, -5,-10
gdT cells Keratinocyte proliferation, differentiation,
hyaluronan synthesis in Kc
FGF-7, FGF-10, and IGF-1,
bFGF, basic fibroblast growth factor; FGF, fibroblast growth factor; MC, mast cell; PDGF, platelet-
derived growth factor; PMN, polymorphonuclear leukocyte; ROS, reactive oxygen species; TGF,
transforming growth factor; TNF, tumor necrosis factor; uPA, urokinase-type plasminogen activator;
VEGF, vascular endothelial growth factor.
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et al., 2000) have all shown a dramatic
delay in wound closure that was asso-
ciated with a significantly reduced infil-
tration of neutrophils and macrophages.
Mast cells. Mast cells are an additional
leukocyte subset present in the skin and
they are an important source of a
variety of proinflammatory mediators
and cytokines that can promote inflam-
mation and vascular changes. There-
fore, they are considered to be involved
in tissue repair. Following injury resi-
dential mast cells degranulate within
hours and thus may become less
apparent. Mast cell levels return to
normal around 48 hours post-injury,
and then increase in number as tissue
repair proceeds (Trautmann et al.,
2000). Analysis on the impact of mast
cell deficiency in mice has been contra-
dictory. Egozi et al. (2003) reported that
mast cell-deficient mice (WBB6F1/J-
kitw/KitWV) showed a decreased num-
ber of neutrophils at the wound site,
whereas macrophage and T-cell infil-
tration was normal. In these studies,
mast cell deficiency had no significant
effect on epithelialization, collagen
synthesis, or angiogenesis. These results
suggest that mast cells modulate the
recruitment of neutrophils into the site
of injury. However, in normal uncom-
plicated conditions mast cells are un-
likely to exert functions that are rate
limiting for repair in mice. Iba et al.
(2004) partially confirmed these results
by demonstrating a significant effect of
mast cell deficiency (W/Wv mice) on
collagen deposition and tissue remodel-
ing in the late phase of repair, however
wound closure rate was not effected by
mast cell deficiency. Recently, both
studies have been challenged by a
report describing a significant impact
of mast cell deficiency on vascular
permeability, PMN influx, and ulti-
mately wound closure rate (Weller
et al., 2006). Further studies are re-
quired to better understand the impact
of mast cells on the healing response
and to clarify whether differences in
model systems used may account for
the diverse effects observed.
T cells. During the phase of tissue
remodeling, when wound closure has
been completed, and local infections
are already overcome, cells of the
adaptive immune response, in particular
T cells constitute the most frequent
leukocyte subset in human skin wounds
(Fishel et al.,. 1987; Engelhardt et al.,
1998). Chemokines are crucial media-
tors for lymphocyte chemotaxis and
function (Baggiolini 1998; Luster et al.,
1998; Rossi and Zlotnik, 2000). Lym-
phocyte accumulation is associated
with the initial appearance of MCP-1 4
days after injury by the chemokines IFN-
g-inducible protein-10 and monokine
induced by IFN-g. Macrophages appear
to be a major source for these cytokines.
IFN-g is a major inducer of inducible
protein-10 and monokine induced by
IFN-g, which could reflect a major shift
in cytokine expression profile from
proinflammatory mediators to IFN-g.
IFN-g gene deficiency leads to an
accelerated healing response, most
likely mediated by enhanced TGF-b1
levels at the wound site, consequent
augmented TGF-b1-mediated signaling
pathway and accelerated collagen de-
position (Ishida et al., 2004). The
number of neutrophils, macrophages,
and T cells were significantly reduced at
the wound site of IFN-g-deficient mice,
most likely due to the lack of endothe-
lial activation. These data may support a
role for T cells in tissue remodeling.
Definitive understanding of T-cell func-
tion, in particular the role of particular
T-cell subsets during repair requires
further investigation. It is likely that
Th1- and Th2-cell subsets differentially
regulate the wound microenvironment
by secreting distinct cytokine profiles
(Azouz et al., 2004; Park and Barbul
2004). Along these lines Th1 cells are
characterized by the release of IFN-g, IL-
2, and TNF-a, whereas Th2 cells classi-
cally release IL-4, -5, and -10. The
expression pattern of both cytokine
profiles has been associated with di-
verse processes of tissue remodeling. T
cells might also influence the healing
response by direct cell–cell interactions
with resident and non-resident cells at
the wound site. Interactions between
the membrane-bound glycoprotein
CD40 and CD40 ligand are reported to
play an important role in these interac-
tions. CD40 ligand-expressing T cells
interact with CD40-expressing keratino-
cytes, fibroblasts, platelets, and macro-
phages, altering their expression profile
of inflammatory mediators, and conse-
quent repair functions (Yellin et al.,
1995; Henn et al., 1998; Kaufman
et al., 2001).
Havran and co-workers recently
reported on the role of a unique
population of gd T lymphocytes in
epidermal repair in the skin (Jameson
et al., 2002). Skin gd T cells are
designated dendritic epidermal T cells
(DETC), and they are strictly limited in
their distribution to the epidermis
(gdDETC). They recognize an, as yet
unidentified antigen, expressed by da-
maged stressed, or transformed kerati-
nocytes in the epidermis. The role of
gdDETC in tissue repair is based on
wound healing studies in gdDETC-
deficient mice, which showed a de-
layed healing response following me-
chanical injury. gd DETCs have been
identified as important source of key
growth factors such as fibroblast growth
factor-7, -10, as well as IGF-1 thereby
regulating keratinocyte proliferation
and differentiation (Jameson et al.,
2002; Sharp et al., 2005). In addition,
this population of T cells was recently
shown to be involved in keratinocyte-
mediated hyaluronan deposition in the
extracellular matrix, and inducing sub-
sequent macrophage infiltration into the
wound site (Jameson et al., 2005).
Taken together, these results demon-
strate a novel function for skin gd T cells
and provide a new perspective on
T-cell regulation in tissue repair.
Mechanisms of inflammatory resolu-
tion. Successful repair after tissue injury
requires resolution of the inflammatory
response. However, whereas the
knowledge about mechanisms and mo-
lecules inducing and perpetuating the
inflammatory response is constantly
increasing, mechanisms, that limit and
down regulate this activity are less
appreciated. Such mechanisms might
include: downregulation of chemokine
expression by anti-inflammatory cyto-
kines such as IL-10 (Sato et al., 1999) or
TGF-b1 (Ashcroft et al., 1999a, 1999b;
Werner et al., 2000), or upregulation of
anti-inflammatory molecules like IL-1
receptor antagonist or soluble TNF
receptor; resolution of the inflammatory
response mediated by the cell surface
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receptor for hyaluronan CD44 (Teder
et al., 2002; Jiang et al., 2005); apoptosis
(Greenhalgh 1998), receptor unrespon-
siveness or downregulation by high
concentrations of ligands (Figure 1). In-
terestingly, recent in vitro data suggested
that matrix metalloproteinases (MMPs)
can downregulate inflammation via clea-
vage of chemokines, which then act as
antagonists (McQuibban et al., 2000,
2002). However, the relevance of these
mechanisms for cutaneous tissue repair
has to be further investigated. In recent
studies, Nrf-2, a target of the keratinocyte
growth factor-1 was identified as novel
transcription factor regulating the inflam-
matory response during repair. The
wound healing response in Nrf-2 knock-
out mice was characterized by a pro-
longed inflammatory response following
wound closure, which was most likely
mediated by prolonged expression of IL-
1b and TNF-a (Braun et al., 2002).
Inflammation directs the quality of tissue
repair
Scar formation is the physiological and
inevitable end point of mammalian
wound repair and there is substantial
evidence that inflammation is an essen-
tial prerequisite for scarring. Although,
normal scar tissue provides a stable
restoration of the skin barrier, the new
tissue is inferior with respect to important
structural, aesthetic and functional as-
pects. The notion has emerged that in the
mammal, wound repair is evolutionary
optimized for speed of healing under
dirty conditions, where a multiply re-
dundant, compensating, rapid inflamma-
tory response, allows the wound to heal
quickly without infection. Thus, a scar
may therefore be the price mammalians
have to pay for evolutionary survival
after wounding (Bayat et al., 2003).
There is considerable quantitative
and qualitative variation in scarring
potential between species and even
among various body sites and organs.
In the human pathological conditions
and genetic disorders can lead to
excessive scarring such as in hyper-
trophic scars or keloids, which might
become severe health problems.
Although the underling mechanisms
for the differences in the outcome of
scarring is not well understood so far,
there is substantial experimental and
clinical evidence that differences in
scarring reflect an altered inflammatory
and/or cytokine profile between indivi-
duals or in a disease state (Harty et al.,
2003; Martin and Leibovich, 2005).
Thus, a better understanding in cellular
and molecular mechanisms in inflam-
matory processes controlling scarring
will serve as a significant milestone in
the studies of tissue repair. The implica-
tions for therapeutic applications in
wound management and in diseases
where scarring is the basic pathogenic
mechanism would be significant.
There are several situations that
provide clear evidence that the inflam-
matory phase during repair is intimately
linked to the extent of scar formation.
First, in contrast to post-natal repair,
wound healing in early fetal skin
exhibits scarless regeneration of the
dermal architecture. Although there
are numerous intrinsic and extrinsic
differences between the fetus and adult
that may influence tissue repair, the
hallmark of fetal repair is the lack of a
typical inflammatory response (Bullard
et al., 2003; Reed et al., 2004). This
minimal fetal inflammatory response
may play a pivotal role in the unique
fetal repair process (Adolph et al., 1993;
Dillon et al., 1994). In support of this
concept, scar formation appears to be
accelerated when inflammation is pro-
voked in fetal wounds (Whitby and
Ferguson, 1991). Liechty et al. (2000)
wounded embryonic skin from IL-10-
deficient mice that had been trans-
planted to strain-matched adult mice.
IL-10 is a central immunosuppressive
cytokine regulating innate and adaptive
immune responses. Whereas control
embryonic skin grafts showed little
inflammation and scarless healing,
wounded IL-10 (/) grafts were char-
acterized by a significantly higher
inflammatory cell infiltration and col-
lagen deposition and an adult-like
scarring response (Liechty et al., 2000).
A second example indicating that
inflammation plays a major role in the
etiology of scarring is evident from
studies investigating the influence of
reproductive hormones on this process.
These studies demonstrated that re-
duced systemic estrogen levels in
ovariectomized mice results in a mark-
edly impaired rate of healing asso-
ciated with excessive inflammation
and scarring (Ashcroft et al., 1997,
1999a, 1999c, 2003; Margolis et al.,
2002). Evidence suggests that a crucial
mechanism underlying the responses to
estrogen involves a dampening of the
inflammatory response, resulting in
reduced proteolytic activity and en-
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Figure 1. Mediators and mechanisms of inflammation and inflammatory resolution in repair. Tissue
injury causes the immediate onset of acute inflammation mediated by chemoattractants derived from
plasma proteins, resident and recruited hematopoetic cells, extracellular matrix and bacteria. Progression
to complete wound healing is accompanied by resolution of the inflammatory response, which is
essential for successful repair. Resolution of inflammation is directed by downregulation of
proinflammatory mediators and the reconstitution of normal microvascular permeability, which
contributes to the cessation of local chemoattractants, synthesis of anti-inflammatory mediators,
apoptosis, and lymphatic drainage. An excessive or prolonged inflammatory response results in increased
tissue injury and poor healing. Successful wound repair requires the coordinate expression of both
inflammation and resolution of inflammation.
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hanced matrix deposition (Ashcroft
et al., 1999a, 1999b). Recent evidence
indicates that macrophage migration
inhibitory factor, an important regula-
tor of inflammation, is a crucial med-
iator of excessive inflammation in the
absence of estrogens (Ashcroft et al.,
2003). Interestingly, no significant dif-
ferences in the rate of healing were
observed between intact wild-type and
migration inhibitory factor null mice,
suggesting that in the presence of
estrogens the absence of migration
inhibitory factor has no effect on the
wound healing response (Ashcroft
et al., 2003; Hardman et al., 2005).
Increased influx of neutrophils and
macrophages does not inevitably result
in an increased scarring response.
Studies examining wound healing in
the elderly revealed that neutrophil
invasion and particularly the number
of mature macrophages at the wound
site is significantly increased in aged
animals and humans (Ashcroft et al.,
1998, 2002; Swift et al., 2001). How-
ever, acute wounds in aged human and
animal models, although delayed, heal
with a better quality of scarring com-
pared to their young counterparts. In
these models healing occurred with
regeneration of the dermal architecture,
and in an improved macroscopic and
microscopic scar appearance resem-
bling more closely that of normal skin
(Ashcroft et al., 2002). The regenerative
appearance of dermal collagen, elastin,
and fibrillin arcades may reflect activa-
tion of the mechanisms responsible for
the developmental formation of such
fiber frameworks. Similar to fetal repair,
levels of TGF-b in wounds of the elderly
are markedly reduced, and this phe-
nomenon might represent the under-
lying mechanism of reduced scarring
observed with age. Further studies are
required to identify mechanisms that
spare the aged skin from scarring
despite an increased inflammation.
Genetic mouse models for inflammation
and healing
Genetically modified mouse models
have proven to be of immense help to
dissect the contribution of specific
immune modulators in tissue repair
(Table 2). Proinflammatory cytokines
such as IL-1a, IL-1b, IL-6, and TNF-a
have been shown to be pivotal media-
tors during different cutaneous inflam-
matory processes (Hu¨bner et al., 1996;
Werner and Grose, 2003). Proinflam-
matory cytokines are strongly upregu-
lated during the inflammatory phase of
healing and beside several resident cell
types of the skin, neutrophils, and
macrophages are both major sources
and targets of proinflammatory cyto-
kines. A critical role of proinflamma-
tory mediators in leukocyte function is
evident in skin wounds of mice defi-
cient for the TNF receptor TNF-Rp55.
Despite a significant reduction in leu-
kocyte infiltration at the wound site,
wounds showed an increase in angio-
genesis, collagen content, reepithelia-
lization, and expression of various
growth factors and their receptors.
(Mori et al., 2002). Ultimately, TNF-
Rp55 deficiency, and presumably lack
of TNF-a signaling, resulted in acceler-
ated wound closure. Along these lines,
wound repair in mice deficient for the
antagonist for IL-1 was delayed re-
flected by reduced angiogenesis and
collagen deposition (Ishida et al.,
2006). Influx of neutrophils was in-
creased during repair in IL-1 receptor
antagonist-deficient mice, implicating
an inhibitory effect of PMNs on wound
closure. In contrast, wound repair in IL-
6-deficient mice was significantly de-
layed (Gallucci et al., 2000). In addi-
tion to a decreased inflammatory
response, granulation tissue formation
and reepithelialization was dramati-
cally reduced in these mice. These
studies highlight the importance of
proinflammatory mediators and leuko-
cytes in the healing response, whereas
Table 2. Genetic mouse models of inflammation and healing
Gened KO/TG
Inflammatory
response
Wound
phenotype Reference
PMN MU
T cells
(CD3+) Epithelialization Angiogenesis
Collagen
deposition
Wound
closure
TNF-
Rp55
KO k k n m m m m Mori et al.,
2002
IL-1ra KO m NA NA NA k k k Ishida et al.,
2006
IL-6 KO Inflammation k k k k Gallucci et al.,
2000
MCP-1 KO NA n NA k k k k Low et al.,
2001
MIP-1a KO n n n n n n n Low et al.,
2001
CXCR2 KO k k NA k k NA k Devalaraja
et al.,
2000
IP-10 TG m m n k k NA k Luster et al.,
1998
IFN-g KO k k k m m m m Ishida et al.,
2004
PU.1 KO k k NA n NA n* n Martin et al.,
2003
Smad3 KO k k NA m NA k m Ashcroft et al.,
1999a
SLPI KO m m NA k NA NA k Ashcroft et al.,
2000
MIF KO N n n n n n n Ashcroft et al.,
2003
IL-10 KO N m NA m m m m Eming et al.
(in press)
KO, knockout; n, normal; NA, not assessed; MCP, monocyte chemoattractant protein; MIP,
macrophage inflammatory protein; PMN, polymorphonuclear leukocyte; SLPI, secretory leukocyte
protease inhibitor; TG, transgenic; TNF, tumor necrosis factor.
*Reduced scar.
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pointing to the involvement of non-
leukocyte cell subsets that can direct
the outcome of the repair response.
Beside the ‘‘classical’’ mediators of
inflammation such as growth factors
and proinflammatory cytokines, che-
mokines are also critically involved
(Lusier, 1998). Engelhardt et al. (1998)
had demonstrated the expression of
distinct repertoires of chemokines in
normal healing of adult skin wounds,
that correlated spatially and temporally
with the phase-specific recruitment of
leukocyte subsets. In recent years,
genetically modified mouse models
with altered expression of specific
chemokines or their receptors have
allowed the elucidation of specific
roles in repair, in particular during the
inflammatory phase. In MCP-1 knock-
out animals, which lack one of the
major macrophage chemoattractants,
the total number of macrophages at
the wound site was not altered,
although wound reepithelialization,
angiogenesis, and collagen synthesis
were significantly delayed in these
mice (Low et al., 2001). Deficiency of
another important regulator of macro-
phage chemotaxis, macrophage inflam-
matory protein 1a, did not result in any
healing defect in mice (Low et al.,
2001). These data clearly demonstrate
the importance of MCP-1a during
wound repair and suggests that the role
played by MCP-1a in healing wounds
consists most likely in influencing the
effector phase of macrophages (and
possibly of other cells types) rather
than simply modulating their number.
A recent study indicates a compensa-
tory upregulation of redundant chemo-
kines in the MCP-1a knockout mouse,
that might account for the normal
macrophage infiltration at the wound
site (Ferreira et al., 2005). Mice lacking
CXCR2, the receptor for the potent
neutrophil chemoattractant macro-
phage inflammatory protein 1a (mouse
homolog for growth-related oncogene-
a), exhibited defective neutrophil and
macrophage recruitment into the
wound site and a reduced angiogenic
response. These alterations resulted in a
significant delay in wound closure
(Devalaraja et al., 2000). This chemo-
kine-receptor knockout model supports
a crucial function for neutrophils and
macrophages in wound healing and
highlight the role of CXCR2 in leuko-
cyte chemotaxis during repair.
In the late inflammatory phase of
wound repair, T lymphocytes appear in
the wound bed. The IFN-g-inducible
chemokines inducible protein-10 and
monokine induced by IFN-g are strong
chemoattractants for T cells and might
regulate their infiltration into the wound
site. Constitutive, transgenic expression
of inducible protein-10 in keratinocytes
caused an intense inflammatory phase,
primarily consisting of macrophages
and neutrophils. This, a prolonged,
disorganized granulation phase resulted
in impaired angiogenesis with de-
creased reepithelialization and ulti-
mately delayed wound closure (Luster
et al., 1998). Surprisingly, the number
of T cells was not significantly different
in comparison to wounds in wild-type
mice. This data suggests that inducible
protein-10 is able to disrupt and impair
the normal healing response. Consistent
with the concept that an exaggerated
inflammatory response might be harm-
ful for repair is the observation in recent
wound healing studies in the IFN-g
knockout mouse. This mouse model
revealed a decreased inflammatory
response at the wound site, however
granulation tissue formation, angiogen-
esis and ultimately wound closure was
significantly improved in IFN-g-defi-
cient mice (Ishida et al., 2004). This
data intend that IFN-g and some of its
downstream targets are negative regu-
lators of the healing response.
In contrast to the generation of mouse
models to identify the role of a single
mediator coordinating inflammation dur-
ing repair, Martin and coworkers posed
the more complex question whether the
influx of neutrophils and macrophages is
essential for cutaneous healing. These
studies investigated perinatal repair in
the PU.1 null mouse, which lacks cells of
the myeloid lineage (macrophages, neu-
trophils, mast cells, eosinophils) and B
cells (McKercher et al., 1996; Martin
et al., 2003). In newborn mutants, little
inflammation occurred at the wound
site. In contrast to the prevailing dogma,
the healing occurred with a similar time
course to wild-type siblings, and repair
appeared scar free, resembling fetal
wound repair. This study demonstrates
the crucial impact of the inflammatory
response on healing. The authors con-
clude that inflammation is not an essen-
tial prerequisite for efficient tissue repair.
However, in these studies one has to
consider that besides the reduced in-
flammatory response, factors intrinsic to
the neonatal microenvironment are
likely to contribute to the superior
healing phenotype. Furthermore, these
studies come with the caveat that in the
model used, wounds were significantly
smaller in size (2mm) when compared to
other murine healing models (4–6mm)
and might not heal by contraction. In
line with the notion that inflammation is
not essential for healing or even retards
the healing process, are recent knockout
studies that examined the role of TGF-b1
in repair. TGF-b1 is a pivotal, pluripotent
mediator in tissue repair, which contri-
butes to both the influx and activation of
inflammatory cells, as well as immune
suppressive effects (Ashcroft 1999b). In-
tracellular signaling of TGF-b1 is
mediated primarily by the Smad family
of proteins. Skin wound healing in mice
deficient in Smad3 was significantly
accelerated despite reduced leukocyte
infiltration (Ashcroft et al., 1999a).
Secretory leukocyte protease inhibi-
tor is a serine proteinase inhibitor
predominantly found in the airways
but also expressed in skin. Mice ge-
netically deficient for secretory leuko-
cyte protease inhibitor showed delayed
cutaneous wound healing. Secretory
leukocyte protease inhibitor, which is
expressed during cutaneous repair, has
an anti-inflammatory activity and also
antagonizes the lipopolysaccharide-in-
duced synthesis of proinflammatory
mediators by macrophages. The defi-
ciency of secretory leukocyte protease
inhibitor in these mice enhanced the
inflammatory response and the elastase
activity at the wound site, which
ultimately led to delayed healing (Ash-
croft et al., 2000).
Taken together, current transgenic
and knockout mouse models generated
to address the role of the inflammatory
response during repair highlight the
view that inflammation is crucial dur-
ing repair and suggest that the inflam-
matory response might provide a
central target to modulate the outcome
of the healing response. The network of
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mediators which orchestrates the in-
flammatory response is complex and
likely redundant. Mediators originally
thought to be primarily involved in the
regulation of leukocyte cell function
have been shown to be pluripotent and
they target non-leukocyte cell compart-
ments during cutaneous wound heal-
ing. Thus, further studies are required
to understand in more detail the
inflammatory response during repair
at its molecular and cellular level.
Excess inflammation associated with im-
paired wound healing
Wound healing disorders in the clinic
present as hypertrophic scars or as non-
healing chronic wounds (ulcers), the
latter presenting the most prevalent
wound healing problems in man. Most
chronic wounds are associated with a
small number of well defined, clinical
entities, in particular venous insuffi-
ciency, diabetes mellitus, pressure ne-
crosis, and vasculitis (Singer and Clark,
1999; Eming et al., 2002, 2006; Scharf-
fetter-Kochanek et al., 2003). Despite
this heterogeneity most non-healing
wounds fail to progress through the
normal phases of wound repair, but
instead remain in a chronic inflamma-
tory state (Loots et al., 1998). Both
underlying systemic defects and local
stimuli might contribute to prolong the
inflammatory phase of the local healing
response, thereby generating a cascade
of tissue responses that generate and
amplify the hostile microenvironment
(Figure 2). One of the most severe
systemic defects affecting the indivi-
dual’s inflammatory reaction and the
wound healing response is pyoderma
gangrenosum. Effective treatment of this
disease is only achieved by immune
suppression. In addition, factors intrinsic
to underlying metabolic disease, such as
diabetic hyperglycemia, or increased
hydrostatic pressure associated with
venous disease, can enhance and per-
petuate the inflammatory response. Tis-
sue hypoxia, bacterial components,
foreign bodies and fragments of necrotic
tissue are powerful local stimuli that are
capable sustaining a continued influx of
neutrophils and macrophages (Figure 2)
(Singer and Clark, 1999; Eming et al.,
2002). As recently shown, bacterial
components may contribute to impaired
repair mechanisms of the host by
interference with cell–matrix interac-
tions or attenuating the inflammatory
response (Chavakis et al., 2002; Atha-
nasopoulos et al., 2006).
A cardinal feature of non-healing
wounds and a major consequence of
the persistent inflammatory response at
the wound site is the unbalanced
proteolytic activity, which overwhelms
local tissue protective mechanisms.
Indeed, there is compelling evidence
that the unrestrained protease activity is
one of the major underlying pathome-
chanisms of non-healing wounds (Pa-
lolathi et al., 1993; Harris et al., 1995;
Saarialho-Kere, 1998; Barrick et al.,
1999). In addition to cells in the wound
site, such as activated keratinocytes at
the wound edge, fibroblasts, and en-
dothelial cells, all of which increase
their expression of different protease
classes, invading neutrophils and
macrophages are considered to be the
major source of numerous proteases.
The expression and the activity of
various MMP classes, including col-
lagenases (MMP-1, MMP-8), gelati-
nases (MMP-2, MMP-9), stromelysins
(MMP-3, MMP-10, and MMP-11), as
well as the membrane type MMP (MT1-
MMP) have been shown to be highly
upregulated in chronic venous stasis
ulcers (Saarialho-Kere, 1998; Norgauer
et al., 2002). Proinflammatory cyto-
kines are considered as potent inducers
of MMP expression in chronic wounds,
and they have been shown to down
regulate the expression of tissue inhi-
bitor of metalloproteinases, thus creat-
ing an environment with a relative
excess of MMP activity. In addition,
elevated levels of various serine protei-
nases have been found at the chronic
wound site, particularly of neutrophil
origin. These include cathepsin G,
urokinase-type plasminogen activator,
and particularly neutrophil elastase
(Grinnell et al., 1992; Grinnell and
Zhu, 1996; Barrick et al., 1999). As a
consequence of the highly proteolytic
microenvironment, mediators crucial
for repair become targets of wound
proteases. Indeed, the major protease
inhibitors a1-proteinase inhibitor and
a2-macroglobulin, as well as compo-
nents of the provisional wound matrix
such as fibronectin and vitronectin,
have been shown to be degraded and
inactivated within the chronic wound
E-selectin
ICAM-1
LFA-1
VLA-4
VCAM-1
MΦ
Blood flow
PMN
Bacterial components
Amplify inflammation
Interaction with cytokines / ECM
Extravasation of
Proteases↑ / protease inhibitors↓
inflammatory cells ↑
IL-1
IL-6
Lipidperoxide
IL-1, TNF-
TGF-, VEGF
Phagocytosis
elastase
MMP-8
MMP-1
MMP-2
MMP-3
MMP-9
MMP-13
gelatinase
Degradation of cytokines/ECM
ROS (H2O2, O2−)
PDGF, bFGF
.
.
.
Figure 2. Model of multifactorial molecular and cellular mechanisms deleterious in tissue repair.
Chronic wounds fail to progress through the normal pattern of wound repair, but instead remain in a state
of chronic inflammation predominantly characterized by abundant PMN and MF infiltration. Persisting
inflammatory cells play a major role in the generation of proinflammatory cytokines (IL-1, TNF-a, and IL-
6) and a protease rich and pro-oxidant hostile microenvironment. Increased proteolytic activity
(neutrophil elastase, MMP-8, and gelatinase) leads to degradation of growth factors and structural
proteins of the extracellular matrix crucial for repair. Increased ROS (H2O2, O2
) can lead to direct
damage of cells or extracellular matrix molecules, or contribute to increased expression of MMPs (MMP-
1, -2, -3, -9, and 13). Bacterial components (extracellular adherence protein (Eap), formyl methionyl
peptides, N-acetylmuramyl-L-alanyl-D-isoglutamine) may contribute to impaired repair mechanisms of
the host by interference with cell–matrix interactions or promoting the inflammatory response.
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environment (Grinnell et al., 1992;
Grinnell and Zhu, 1996). Growth
factors pivotal for repair such as plate-
let-derived growth factor or vascular
endothelial growth factor are targets of
wound proteases, and they are inacti-
vated by proteolytic cleavage
(Wlaschek et al., 1997; Lauer et al.,
2000, 2002; Roth et al., 2006).
The chronic wound is a highly pro-
oxidant microenvironment (Mendez
et al., 1998; Wenk et al., 2001; James
et al., 2003; Wlaschek and Scharffetter-
Kochanek, 2005). Leukocytes, espe-
cially neutrophils are a rich source of
various ROS (superoxide anion, hydro-
xyl radicals, singlet oxygen, hydrogen
peroxide), which are released into the
wound environment (Weiss, 1989).
Endothelial cells and fibroblasts, in
particular senescent fibroblasts, which
are prominent in chronic wounds, are
also potential sources for ROS (Campi-
si, 1996; Mendez et al., 1998). Evi-
dence for a prominent role of ROS in
multiple steps of the pathogenesis of
non-healing wounds comes from sev-
eral in vitro and in vivo studies
(Wlaschek and Scharffetter-Kochanek,
2005). In addition to direct damage of
cell membranes and structural proteins
of the extracelluar matrix, ROS can
selectively affect signaling pathways
leading to the activation of transcrip-
tion factors that control the expression
of proinflammatory cytokines (IL-1, -6,
and TNF-a), chemokines and proteoly-
tic enzymes including MMPs and ser-
ine proteinases (Wenk et al., 2001).
Thus, the disturbed oxidant/antioxidant
balance within the chronic wound
microenvironment is considered a ma-
jor factor, which amplifies the unrest-
rained and persistent inflammatory
state of non-healing wounds.
Based on these observations it is a
well-accepted concept that effective
therapy toward healing of the chronic
wound must disrupt this proinflamma-
tory cycle. Unraveling pro- and anti-
inflammatory pathways in tissue repair
might be an important avenue to devel-
op protective strategies, which shield
the regenerative tissue from damage
caused by the chronically inflamed
microenvironment of the non-healing
wound. The excessive and unbalanced
inflammation characterizing the chronic
wound suggests a promising target for
future therapeutic interventions.
Chronic inflammation associated with
malignant progression in chronic wounds
It has long been known that chronic
wounds are at risk for neoplastic
progression (Baldursson et al., 1993,
1995, 1999). The risk of squamous cell
carcinoma (SCC) is markedly in-
creased, suggesting that keratinocytes
are especially vulnerable to malignant
transformation. Very little is known
about the molecular inducers of tumor-
genesis in chronic wounds. The main
cause of cutaneous SCC, UV irradia-
tion, is an unlikely explanation. A
recent study investigating cell cycle
regulators in SCCs associated with
venous leg ulcers suggests differing
mechanisms of carcinogenesis in ve-
nous leg ulcers and UV-induced SCC
(Baldursson et al., 2000a, 2000b).
Furthermore, SCC of the skin has also
been associated with human papillo-
mavirus infection. Interestingly, human
papillomavirus has been detected in
verrucous carcinomas of the leg and
foot (Garven et al., 1991; Noel et al.,
1993) and human papillomavirus in-
fection could play a role in SCC arising
from chronic leg ulcers. So far this topic
has been poorly investigated.
The tumor cell microenvironment,
in particular the tumor stroma, appears
to play an important role in the control
of neoplastic progression through dy-
namic reciprocity between tumor cells
and their surrounding tissue (Bissell and
Radisky, 2001; Mueller and Fusenig,
2004). The inflammatory response
within the tumor stroma, which is
closely linked to fibroplasia and angio-
genesis, has been considered to play a
critical role in carcinogenesis (Balkwill
and Mantovani, 2001; Coussens and
Werb, 2002; de Visser and Coussens,
2005; Impola et al., 2005). Inflamma-
tion, fibroplasia, and angiogenesis are
cardinal events that are intimately
linked to wound repair. Thus the
chronic inflammatory microenviron-
ment of the non-healing wound could
be a risk factor for malignant transfor-
mation. Two proposed mechanisms
relate the increased inflammatory re-
sponse within the stroma to cancero-
genesis: first, the highly vascularized
and growth factor rich tumor stroma
provides an environment rich in nu-
trients that supports tumor growth;
second, the tumor stroma might di-
rectly stimulate malignant transforma-
tion. For example, so-called
carcinoma-associated fibroblasts med-
iate oncogenic signals (directly or
indirectly) that stimulate the progres-
sion of a non-tumorigenic cell popula-
tion to a tumorigenic one (Phillips
et al., 2001; Tlsty, 2001). Subcutaneous
injection of benign tumorigenic SCC
cells demonstrated an enhanced malig-
nant phenotype upon re-cultivation,
that was associated with the altered
expression of various growth factors,
such as G-CSF and GM-CSF (Mueller
et al., 2001). As a related example,
treatment of cleared mammary fad
pads with the carcinogen N-nitroso-
methyl urea, generated a stromal en-
vironment that was characterized by
the acquisition of genetic mutations
and allowed the development of
epithelial tumors from transplanted
normal mammary epithelial cells (Maf-
fini et al., 2004). Thus the tumor stroma
should be considered as a therapeutic
target in malignant transformation and
tumor growth, and by analogy that ‘‘the
stroma of the chronic wound’’ might
provide a microenvironment that sets
wound keratinocytes at risk for malig-
nant transformation. Experimental
proof for this concept will be challen-
ging, because until today animal mod-
els for chronic wound repair are
lacking. Nevertheless, the identifica-
tion of inflammatory mediators respon-
sible for malignant transformation will
be important in the management of
non-healing wounds, in particular to
predict the development of SCC from
pseudoepitheliomatous hyperplasia of
chronic wounds and potentially in
other chronic inflammatory states asso-
ciated with malignant transformation.
Recently, Ortiz-Urda et al. (2005)
provided molecular evidence for the
development of SCC only in a certain
portion of patients suffering from reces-
sive dystrophic epidermolysis bullosa.
This group showed in an elegant analy-
sis of recessive dystrophic epidermolysis
bullosa keratinocytes that only those
keratinocytes that retained a specific
collagen VII fragment (FNC1 sequence
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within the NC1 domain) were tumori-
genic (Ortiz-Urda et al., 2005). The
invasiveness of epithelial cells required
interaction of the FNC1 domain with
laminin 5. Thus, these studies suggest
that an intact adhesion complex be-
tween the FNC1 domain of collagen VII
and laminin 5 is required for epidermal
cells to receive the stromal signals that
they need to migrate to and invade the
dermal layer. Expression of structural
molecules, generating the adhesion
complex are regulated by dermal med-
iators and it is possible that the tumor–-
stroma interactions mediated by
collagen VII might be relevant for tumor
development in chronic wounds.
Concluding remarks
In summary, numerous clinical and
experimental studies confirm the pivotal
role of inflammation during repair. To
achieve proper tissue homeostasis during
healing, the fine tuned balance between
a complex network of various leukocyte
cell subsets and numerous pro- and anti-
inflammatory mediators is crucial. Dys-
regulation of critical parameters of these
interactions results in pathologic and
chronic inflammatory disease states that
impair the quality of healing. Further
information is required on molecular
pathways that disrupt the physiological
inflammatory phase during repair, in-
cluding underlying systemic diseases
(diabetes mellitus, venous insufficiency)
and/or microbial components, which
contribute to the pathology of wound
healing. Experimental mouse models will
be particular useful to answer these open
questions, because of the ability to
manipulate the genetic, systemic, and
wound environment. Although genetic
eradication of specific mediators and
leukocyte lineages may partially be
compensated by redundant mechanisms,
the chronic wound, through proteolysis,
oxidative stress, and accumulation of
toxic substances, may lead to depletion
of critical resources.
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